BridgeBio Pharma, Inc. (BBIO)

75.15 +1.08 (+1.46%) USD  |  NASDAQ  |  Dec 12, 16:00
75.15 0.00 (0.00%) After-Hours: 20:00
More

BridgeBio Pharma EPS Diluted (TTM): -4.187 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Pfizer Inc. 1.716
Alnylam Pharmaceuticals, Inc. 0.2405
Supernus Pharmaceuticals, Inc. -0.3408
Ionis Pharmaceuticals, Inc. -1.711
Regeneron Pharmaceuticals, Inc. 41.77